Literature DB >> 26081999

Reply to O'Riordan et al.

James A McKinnell1, Sarah M Bartsch2, Bruce Y Lee2, Susan S Huang3, Loren G Miller1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26081999      PMCID： PMC5676467          DOI： 10.1017/ice.2015.112

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  6 in total

1.  Response to McKinnell et al's original article "cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers".

Authors:  Mary Teresa O'Riordan; Patricia Harrington; Kathleen Mac Lellen; Máirín Ryan; Hilary Humphreys
Journal:  Infect Control Hosp Epidemiol       Date:  2015-07       Impact factor: 3.254

2.  Cost savings of universal decolonization to prevent intensive care unit infection: implications of the REDUCE MRSA trial.

Authors:  Susan S Huang; Edward Septimus; Taliser R Avery; Grace M Lee; Jason Hickok; Robert A Weinstein; Julia Moody; Mary K Hayden; Jonathan B Perlin; Richard Platt; G Thomas Ray
Journal:  Infect Control Hosp Epidemiol       Date:  2014-10       Impact factor: 3.254

3.  Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers.

Authors:  James A McKinnell; Sarah M Bartsch; Bruce Y Lee; Susan S Huang; Loren G Miller
Journal:  Infect Control Hosp Epidemiol       Date:  2015-01       Impact factor: 3.254

4.  Universal methicillin-resistant Staphylococcus aureus (MRSA) surveillance for adults at hospital admission: an economic model and analysis.

Authors:  Bruce Y Lee; Rachel R Bailey; Kenneth J Smith; Robert R Muder; Elsa S Strotmeyer; G Jonathan Lewis; Paul J Ufberg; Yeohan Song; Lee H Harrison
Journal:  Infect Control Hosp Epidemiol       Date:  2010-06       Impact factor: 3.254

5.  Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus.

Authors:  Gijs Hubben; Martin Bootsma; Michiel Luteijn; Diarmuid Glynn; David Bishai; Marc Bonten; Maarten Postma
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

6.  Cost comparison of MRSA screening and management - a decision tree analysis.

Authors:  Andrea Tübbicke; Claudia Hübner; Nils-Olaf Hübner; Christian Wegner; Axel Kramer; Steffen Fleßa
Journal:  BMC Health Serv Res       Date:  2012-12-01       Impact factor: 2.655
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.